1. Home
  2. ADVM vs WFCF Comparison

ADVM vs WFCF Comparison

Compare ADVM & WFCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • WFCF
  • Stock Information
  • Founded
  • ADVM 2006
  • WFCF 1996
  • Country
  • ADVM United States
  • WFCF United States
  • Employees
  • ADVM N/A
  • WFCF N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • WFCF Computer Software: Prepackaged Software
  • Sector
  • ADVM Health Care
  • WFCF Technology
  • Exchange
  • ADVM Nasdaq
  • WFCF Nasdaq
  • Market Cap
  • ADVM 47.4M
  • WFCF 53.4M
  • IPO Year
  • ADVM 2014
  • WFCF 2011
  • Fundamental
  • Price
  • ADVM $2.39
  • WFCF N/A
  • Analyst Decision
  • ADVM Strong Buy
  • WFCF
  • Analyst Count
  • ADVM 5
  • WFCF 0
  • Target Price
  • ADVM $23.80
  • WFCF N/A
  • AVG Volume (30 Days)
  • ADVM 338.5K
  • WFCF 6.1K
  • Earning Date
  • ADVM 08-11-2025
  • WFCF 08-07-2025
  • Dividend Yield
  • ADVM N/A
  • WFCF N/A
  • EPS Growth
  • ADVM N/A
  • WFCF N/A
  • EPS
  • ADVM N/A
  • WFCF 0.38
  • Revenue
  • ADVM $1,000,000.00
  • WFCF $25,437,000.00
  • Revenue This Year
  • ADVM N/A
  • WFCF N/A
  • Revenue Next Year
  • ADVM $18.82
  • WFCF N/A
  • P/E Ratio
  • ADVM N/A
  • WFCF $30.18
  • Revenue Growth
  • ADVM N/A
  • WFCF N/A
  • 52 Week Low
  • ADVM $1.78
  • WFCF $9.26
  • 52 Week High
  • ADVM $10.14
  • WFCF $13.50
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 44.75
  • WFCF 60.86
  • Support Level
  • ADVM $2.11
  • WFCF $10.85
  • Resistance Level
  • ADVM $2.60
  • WFCF $11.38
  • Average True Range (ATR)
  • ADVM 0.22
  • WFCF 0.29
  • MACD
  • ADVM -0.00
  • WFCF 0.13
  • Stochastic Oscillator
  • ADVM 36.39
  • WFCF 83.75

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

About WFCF Where Food Comes From Inc.

Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.

Share on Social Networks: